Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis.
Saved in:
| Title: | Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis. |
|---|---|
| Authors: | Zhang Q; Department of Interventional Radiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.; Department of Interventional Radiology, Qinghai University Affiliated Hospital, Xining, Qinghai, China., Lei Z; Department of Interventional Radiology, Qinghai University Affiliated Hospital, Xining, Qinghai, China., Qing H; Dongguan Community Health Service Center, Hanzhong, Shaanxi, China., Xie X; Department of Interventional Radiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 16; Vol. 17, pp. 1694973. Date of Electronic Publication: 2026 Apr 16 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1694973 |
